SaigonBao.com

Archive -Daily News

CRISPR Therapy

CRISPR : 2022January30Sunday

CRISPR: Maximizing this Revolutionary Genetic Tool While Minimizing IP Risk - Pharmaceutical Executive

First sickle cell patient treated with CRISPR gene-editing still thriving - NPR

CRISPR Gene-Editing Technology Enters the Body — and Space - DISCOVER Magazine

Moderna, Excision each enter HIV battle with mRNA and CRISPR tech - FierceBiotech

Excision Starts CRISPR Gene-Editing Trial for HIV Patients - Business Insider

Jennifer Doudna: What does CRISPR mean for the future of human evolution? - NPR

Alternative functions of CRISPR–Cas systems in the evolutionary arms race - Nature.com

Better Biotech Stock: CRISPR Therapeutics or Twist Bioscience? - Motley Fool

CRISPR Gene Editing Market, 2031 - ResearchAndMarkets.com - Business Wire

New Virus-Like Particles Can Deliver CRISPR to Any Cell in the Body - Singularity Hub

Genetic Engineering: 2022January30Sunday

Global Genetic Engineering Market Outlook 2022-2028 – Construction News Portal - Construction News Portal

USDA Genetic Engineered Food Label Misleads Consumers, Took Effect January 1 - Beyond Pesticides

Scientists Are Genetically Modifying Climate-Friendly Rice | Time - TIME

Novel Gene Editing Systems Come Into Their Own - Genetic Engineering & Biotechnology News

Can we engineer crops to withstand climate change? - Stanford University News

Researchers identify key regulator of blood stem cell development - Science Daily

U.S. corn production is booming—but its future isn't clear - National Geographic

Ryan Phelan: How gene technology can save species on the brink of extinction - NPR

A pig kidney transplant, and then a pig heart transplant: How GMOs are saving lives - NBC News

CRISPR: Maximizing this Revolutionary Genetic Tool While Minimizing IP Risk - Pharmaceutical Executive

Gene Editing : 2022January30Sunday

First sickle cell patient treated with CRISPR gene-editing still thriving - NPR

Novel Gene Editing Systems Come Into Their Own - Genetic Engineering & Biotechnology News

Excision Starts CRISPR Gene-Editing Trial for HIV Patients - Business Insider

Over $1bn raised in venture capital funding for gene editing in 2021 - Pharmaceutical Technology

UK moves closer to allowing gene editing of crops by allowing more research - The Guardian

Pfizer buys into next-generation gene editing in $300 million deal with Beam Therapeutics - Chemical & Engineering News

Gene editing startup Metagenomi raises $175M to advance research pipeline - BioPharma Dive

The Gene-Editing Industry Weighs In on Outlook at J.P. Morgan Conference - Barron's

First time genome editing made possible on cells lining blood vessel walls: Vast application potential to treat diseases, including acute respiratory distress syndrome from severe COVID-19 - Science Daily

Synthetic viral lookalikes sneak gene-editing tools into cells - Nature.com

CRISPR Therapy : 2022January30Sunday

First sickle cell patient treated with CRISPR gene-editing still thriving - NPR

Moderna, Excision each enter HIV battle with mRNA and CRISPR tech - FierceBiotech

Novel Gene Editing Systems Come Into Their Own - Genetic Engineering & Biotechnology News

The Best CRISPR Companies to Invest In - Motley Fool

New Virus-Like Particles Can Deliver CRISPR to Any Cell in the Body - Singularity Hub

Bayer Strikes "Mammoth" CRISPR Deal to Bolster Cell and Gene Therapy - BioSpace

CRISPR Gene Editing Market, 2031 - ResearchAndMarkets.com - Business Wire

Pfizer, Beam Therapeutics Partner to Develop Treatments for 3 Genetic Diseases - Barron's

JPM22: Aftershocks for Lilly, CRISPR versus CRISPR and Bluebird's crucial year - BioPharma Dive

New drug combo identified for liver cancer via CRISPR-Cas9 screen - Science Daily